EarningsQ4 2025 Earnings Report

Novavax (NVAX) Q4 2025 Earnings Report

0 Followers

MX:NVAX Q4 2025 EPS Results

Actual EPS$2.03

Consensus EPS-$8.93

Beat/MissBeat by +$10.96

One Year Ago EPS-$9.39

Actual Revenue$2.71B

Expected Revenue$1.65B

Beat/MissBeat by +$1.05B

YoY Revenue Growth+66.61%

QuarterQ4 2025

Date02/26/2026

TimeBefore Open

Conference CallThursday, February 26, 2026

MX:NVAX Upcoming Earnings

Novavax's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NVAX Q4 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-3.98 / -	-23.018	―
Aug 06, 2026	2026 (Q2)	-7.00 / -5.89	11.417	-151.61% (-17.31)
May 06, 2026	2026 (Q1)	-4.46 / -1.10	53.954	-102.05% (-55.06)
Feb 26, 2026	2025 (Q4)	-8.93 / 2.03	-9.391	121.57% (+11.42)
Nov 06, 2025	2025 (Q3)	-22.02 / -23.02	-13.995	-64.47% (-9.02)
Aug 06, 2025	2025 (Q2)	0.15 / 11.42	18.23	-37.37% (-6.81)
May 08, 2025	2025 (Q1)	-7.79 / 53.95	-19.335	379.05% (+73.29)
Feb 27, 2025	2024 (Q4)	-9.46 / -9.39	-26.516	64.58% (+17.13)
Nov 12, 2024	2024 (Q3)	-14.57 / -13.99	-23.202	39.68% (+9.21)
Aug 08, 2024	2024 (Q2)	30.75 / 18.23	10.68	70.69% (+7.55)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed